PubRank

Gaetano Thiene

Author PubWeight™ 286.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006 9.44
2 Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004 7.84
3 Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005 6.93
4 Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010 6.71
5 Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006 5.79
6 A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 2009 4.54
7 Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009 4.46
8 Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010 4.13
9 Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 2005 3.99
10 Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 2004 3.54
11 Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003 3.52
12 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013 3.50
13 Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004 3.45
14 Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 2008 3.30
15 Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002 2.95
16 Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm 2009 2.82
17 Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 2006 2.81
18 A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007 2.76
19 Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005 2.56
20 Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003 2.56
21 Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2009 2.37
22 Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005 2.29
23 Myocardial edema underlies dynamic T-wave inversion (Wellens' ECG pattern) in patients with reversible left ventricular dysfunction. Heart Rhythm 2011 2.18
24 Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003 2.12
25 Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations. Heart Rhythm 2011 2.11
26 Concealed metastatic lung carcinoma presenting as acute coronary syndrome with progressive conduction abnormalities. Circulation 2012 2.10
27 Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol 2008 2.09
28 Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 2008 2.06
29 Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J 2008 2.05
30 Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2009 2.00
31 Aortic elasticity and size in bicuspid aortic valve syndrome. Eur Heart J 2007 1.95
32 Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol 2004 1.82
33 Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet 2013 1.81
34 Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch 2007 1.81
35 Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2010 1.62
36 Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J 2009 1.59
37 Scimitar syndrome: a European Congenital Heart Surgeons Association (ECHSA) multicentric study. Circulation 2010 1.59
38 Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates. Hum Pathol 2005 1.57
39 Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J 2006 1.56
40 Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002 1.54
41 Protagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm 2007 1.51
42 Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol 2013 1.49
43 Strategies for the prevention of sudden cardiac death during sports. Eur J Cardiovasc Prev Rehabil 2011 1.48
44 Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants. Cardiovasc Res 2005 1.48
45 Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 2006 1.48
46 Sudden coronary death--not always atherosclerotic. Heart 2010 1.47
47 Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test? Heart Rhythm 2012 1.47
48 Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2005 1.47
49 T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol 2014 1.45
50 Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail 2009 1.44
51 Intracardiac echocardiography: gross anatomy and magnetic resonance correlations and validations. Int J Cardiovasc Imaging 2005 1.38
52 Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation 2004 1.33
53 Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res 2012 1.32
54 Frequency of bicuspid aortic valve in young male conscripts by echocardiogram. Am J Cardiol 2005 1.32
55 Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010 1.31
56 Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol 2011 1.25
57 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 2011 1.24
58 Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations. Eur Heart J 2011 1.24
59 Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc Pathol 2006 1.22
60 Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2012 1.20
61 Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med 2009 1.18
62 An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol 2004 1.17
63 Cerebral protection during carotid artery stenting: collection and histopathologic analysis of embolized debris. Stroke 2002 1.17
64 Surgical vs medical treatment for isolated internal carotid artery elongation with coiling or kinking in symptomatic patients: a prospective randomized clinical study. J Vasc Surg 2005 1.15
65 Bicuspid aortic valve: abnormal aortic elastic properties. J Heart Valve Dis 2002 1.15
66 Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol 2011 1.14
67 Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 2005 1.14
68 Surgically treated primary cardiac tumors in early infancy and childhood. J Thorac Cardiovasc Surg 2005 1.13
69 Italian cardiological guidelines for sports eligibility in athletes with heart disease: part 1. J Cardiovasc Med (Hagerstown) 2013 1.13
70 Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations. Mod Pathol 2004 1.13
71 Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2011 1.11
72 Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Med Genet 2007 1.11
73 Coronary artery anomalies and sudden death. Card Electrophysiol Rev 2002 1.10
74 Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 2003 1.08
75 Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol 2007 1.07
76 Italian cardiological guidelines for sports eligibility in athletes with heart disease: part 2. J Cardiovasc Med (Hagerstown) 2013 1.06
77 Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy. Prog Cardiovasc Dis 2007 1.04
78 Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J 2011 1.04
79 Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 2008 1.01
80 Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J 2010 1.01
81 Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 2008 1.00
82 Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol 2012 1.00
83 Essay: Sudden death in young athletes. Lancet 2005 0.99
84 Infective endocarditis in bicuspid aortic valve: atrioventricular block as sign of perivalvular abscess. Cardiovasc Pathol 2006 0.98
85 Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 2002 0.98
86 Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol 2010 0.97
87 Leaflet escape in a new bileaflet mechanical valve: TRI technologies. Circulation 2003 0.96
88 Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation. Transplantation 2002 0.95
89 Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 2004 0.95
90 Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium. Virchows Arch 2008 0.95
91 Sarcoid myocarditis with ventricular tachycardia mimicking ARVD/C. J Cardiovasc Electrophysiol 2009 0.94
92 Extracellular matrix graft for vascular reconstructive surgery: evidence of autologous regeneration of the neoaorta in a murine model. Eur J Cardiothorac Surg 2012 0.93
93 Spontaneously occurring restrictive nonhypertrophied cardiomyopathy in domestic cats: a new animal model of human disease. Cardiovasc Pathol 2013 0.93
94 Arrhythmogenic cardiomyopathy: transgenic animal models provide novel insights into disease pathobiology. Circ Cardiovasc Genet 2011 0.93
95 Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart 2010 0.93
96 Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythm Electrophysiol 2013 0.93
97 Pathological changes and myocardial remodelling related to the mode of shunting following surgical palliation for hypoplastic left heart syndrome. Cardiol Young 2008 0.92
98 Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. Am J Cardiol 2008 0.92
99 Arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2012 0.91
100 Successful treatment of enterovirus-induced myocarditis with interferon-alpha. J Heart Lung Transplant 2003 0.91
101 Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011 0.90
102 Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: a phenomenon related to immunological events? Am J Transplant 2004 0.90
103 Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg 2003 0.90
104 Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 2010 0.89
105 The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy. Eur J Hum Genet 2010 0.89
106 The clinico-pathological conference, based upon Giovanni Battista Morgagni's legacy, remains of fundamental importance even in the era of the vanishing autopsy. Virchows Arch 2015 0.89
107 Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J 2004 0.89
108 Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts. Transplantation 2005 0.89
109 Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 2004 0.89
110 Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissue. Am J Clin Pathol 2008 0.89
111 Arrhythmogenic right ventricular cardiomyopathy: an update. Heart 2009 0.89
112 Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int 2011 0.89
113 An etymological "autopsy" of Morgagni's title: De sedibus et causis morborum per anatomen indagatis (1761). Hum Pathol 2013 0.89
114 The ARVD/C genetic variants database: 2014 update. Hum Mutat 2015 0.88
115 Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplantation 2010 0.88
116 Cannabis and cocaine: a lethal cocktail triggering coronary sudden death. Cardiovasc Pathol 2007 0.88
117 Screening for hypertrophic cardiomyopathy in a young male military population. Am J Cardiol 2003 0.88
118 Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. Ann Noninvasive Electrocardiol 2003 0.88
119 Myocardial clefts, crypts, or crevices: once again, you see only what you look for. Circ Cardiovasc Imaging 2014 0.87
120 Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. J Heart Lung Transplant 2011 0.87
121 Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. Circulation 2011 0.87
122 Exercise and the risk of sudden cardiac death. Herz 2006 0.86
123 Cardiological guidelines for competitive sports eligibility. Ital Heart J 2005 0.86
124 A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience. J Heart Lung Transplant 2011 0.86
125 Fatal aortoesophageal fistula in two cases of tight vascular ring. Cardiol Young 2002 0.86
126 Bone-marrow-derived CXCR4-positive tissue-committed stem cell recruitment in human right ventricular remodeling. Hum Pathol 2010 0.85
127 Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes. Eur J Hum Genet 2003 0.85
128 Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev 2013 0.85
129 Desmin mutations and arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2012 0.84
130 Echocardiographic diagnosis of aortic valve papillary fibroelastoma. Tex Heart Inst J 2004 0.84
131 [Guidelines on prevention, diagnosis and treatment of infective endocarditis. Executive summary]. Rev Esp Cardiol 2004 0.84
132 Recent developments on coronary microvasculopathy after heart transplantation: a new target in the therapy of cardiac allograft vasculopathy. Curr Vasc Pharmacol 2012 0.84
133 Sudden cardiac death in athletes: what is the role of screening? Curr Opin Cardiol 2012 0.84
134 The changing spectrum of arrhythmogenic (right ventricular) cardiomyopathy. Cell Tissue Res 2012 0.83
135 Heart rate variability in arrhythmogenic right ventricular cardiomyopathy correlation with clinical and prognostic features. Pacing Clin Electrophysiol 2002 0.83
136 Juxtaposition of the atrial appendages. Cardiovasc Pathol 2011 0.83
137 Heart lipid accumulation in obese non-diabetic rats: effect of weight loss. Nutr Metab Cardiovasc Dis 2007 0.83
138 Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model. Eur J Cardiothorac Surg 2008 0.83
139 Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection. J Heart Lung Transplant 2013 0.83
140 Specific characteristics of sudden death in a mediterranean Spanish population. Am J Cardiol 2010 0.83
141 Identification of Giovanni Battista Morgagni remains following historical, anthropological, and molecular studies. Virchows Arch 2014 0.82
142 Endovascular treatment of in-stent restenosis after carotid artery stenting: immediate and midterm results. J Endovasc Ther 2006 0.82
143 Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep. J Thorac Cardiovasc Surg 2006 0.82
144 von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding. Thromb Haemost 2011 0.82
145 How to screen athletes for cardiovascular diseases. Cardiol Clin 2007 0.82
146 Exercise-induced normalization of right precordial negative T waves in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2013 0.82
147 Is it time to include ion channel diseases among cardiomyopathies? J Electrocardiol 2005 0.82
148 Full-sternotomy off-pump versus on-pump coronary artery bypass procedures: in-hospital outcomes and complications during one year in a single center. Tex Heart Inst J 2003 0.82
149 Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants. J Thorac Cardiovasc Surg 2003 0.82
150 The metamorphosis of myocardial infarction following coronary recanalization. Cardiovasc Pathol 2009 0.81
151 Does sports activity enhance the risk of sudden cardiac death? J Cardiovasc Med (Hagerstown) 2006 0.81
152 Hybrid cardiomyocytes derived by cell fusion in heterotopic cardiac xenografts. FASEB J 2006 0.81
153 Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification. Virchows Arch 2014 0.81
154 Arrhythmogenic right ventricular cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. Cardiol Clin 2007 0.81
155 Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011 0.81
156 Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy. Eur J Hum Genet 2013 0.81
157 Antiphospholipid syndrome and right atrial mass. J Thorac Cardiovasc Surg 2005 0.81
158 Sovering annuloplasty rings: experimental pathology in the sheep model. Cardiovasc Pathol 2005 0.81
159 Candida endocarditis complicating transapical aortic valve implantation. Eur Heart J 2011 0.81
160 Revisiting definition and classification of cardiomyopathies in the era of molecular medicine. Eur Heart J 2007 0.81
161 Cocaine and the heart: more than just coronary disease. Heart 2011 0.80
162 Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. J Heart Lung Transplant 2010 0.80
163 Intermediate results of isolated mitral valve replacement with a Biocor porcine valve. J Thorac Cardiovasc Surg 2005 0.80
164 Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology. Cardiovasc Pathol 2011 0.80
165 Images in cardiovascular medicine. Giant aneurysm of the right atrial appendage in a 39-year-old woman. Circulation 2007 0.79
166 Sudden cardiac death in athletes: can it be prevented by screening? Herz 2009 0.79
167 ABO-incompatible heart transplantation: crossing the immunological barrier. J Cardiovasc Med (Hagerstown) 2008 0.79
168 Clefted bicuspid aortic valve. Cardiovasc Pathol 2002 0.79
169 Images in cardio-thoracic surgery: Intimo-intimal intussusception: a rare complication of Stanford type A acute aortic dissection. Eur J Cardiothorac Surg 2009 0.79
170 C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl Int 2005 0.79
171 Three-dimensional molecular reconstruction of rat heart with mass spectrometry imaging. Anal Bioanal Chem 2012 0.79
172 May active myocarditis mimick arrhythmogenic right ventricular cardiomyopathy phenotype by electroanatomic mapping? J Am Coll Cardiol 2009 0.79
173 Prevalence and clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart: relevance to athletic screening. Int J Cardiol 2013 0.78
174 Pro-Apoptotic Effects of Plasma from Patients with Cardiorenal Syndrome on Human Tubular Cells. Am J Nephrol 2015 0.78
175 Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a single gold standard test? J Cardiovasc Electrophysiol 2004 0.78
176 Biological versus mechanical aortic prosthesis? A nineteen-year comparison in a propensity-matched population. J Heart Valve Dis 2005 0.78
177 Commissural dehiscence: a rare and peculiar cause of porcine valve structural deterioration. J Thorac Cardiovasc Surg 2006 0.78
178 Continuous engraftment and differentiation of male recipient Y-chromosome-positive cardiomyocytes in donor female human heart transplants. J Heart Lung Transplant 2007 0.78
179 Sport and arrhythmias: summary of an international symposium. Eur J Cardiovasc Prev Rehabil 2007 0.78
180 Intracoronary artery shunt: an assessment of possible coronary artery wall damage. J Thorac Cardiovasc Surg 2003 0.77
181 Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation. Am J Transplant 2004 0.77
182 Leiomyosarcoma of the left atrium mimicking a left atrial myxoma. J Thorac Cardiovasc Surg 2006 0.77
183 Editorial comment: Pericardial leaflet injury in transcatheter aortic valve implantation: trick or treat. Eur J Cardiothorac Surg 2011 0.77
184 Cardiac sarcoidosis mimicking arrhythmogenic right ventricular cardiomyopathy/dysplasia: the renaissance of endomyocardial biopsy? J Cardiovasc Electrophysiol 2008 0.77
185 Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations. Am J Cardiol 2012 0.77
186 Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation. J Heart Lung Transplant 2008 0.77
187 Arrhythmogenic right ventricular cardiomyopathy: what's in a name? From a congenital defect (dysplasia) to a genetically determined cardiomyopathy (dystrophy). Am J Cardiol 2010 0.77
188 Atrial septal mass: transesophageal echocardiographic assessment. J Thorac Cardiovasc Surg 2004 0.77
189 Arterial switch operation, aortic root dilation, and long-term aortic valve competence. Ann Thorac Surg 2008 0.77
190 Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: an 8-year experience. J Thorac Cardiovasc Surg 2004 0.77
191 Giant congenital aortic aneurysm with cleft sternum in a neonate: pathological and surgical considerations for optimal management. Cardiovasc Pathol 2009 0.77
192 Relevance of apoptosis in influencing recovery of hibernating myocardium. Eur J Heart Fail 2006 0.77
193 Noninvasive cardiac screening in young athletes with ventricular arrhythmias. Am J Cardiol 2012 0.77
194 Giant intramural left ventricular rhabdomyoma in a newborn. Circulation 2011 0.77
195 Exercise prescription for the prevention and treatment of cardiovascular diseases: part I. J Cardiovasc Med (Hagerstown) 2008 0.77
196 A novel kind of tumor type-characteristic junction: plakophilin-2 as a major protein of adherens junctions in cardiac myxomata. Mod Pathol 2010 0.77
197 Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. Cardiol Clin 2007 0.77
198 Determinants of coronary flow reserve in heart transplantation: a study performed with contrast-enhanced echocardiography. J Heart Lung Transplant 2009 0.76
199 Exercise prescription for the prevention and treatment of cardiovascular diseases: part II. J Cardiovasc Med (Hagerstown) 2008 0.76
200 Fatal outcome in Eisenmenger syndrome. Cardiovasc Pathol 2002 0.76
201 Pros and cons of screening for sudden cardiac death in sports. Heart 2013 0.76
202 [Guidelines on the diagnosis and management of pericardial diseases. Executive summary]. Rev Esp Cardiol 2004 0.76
203 Clinical management of arrhythmogenic right ventricular cardiomyopathy: an update. Curr Pharm Des 2010 0.76
204 Pharmacotherapy and other therapeutic modalities for managing Arrhythmogenic Right Ventricular Cardiomyopathy. Cardiovasc Drugs Ther 2015 0.76
205 The contribution of stem cell therapy to skeletal muscle remodeling in heart failure. Int J Cardiol 2013 0.76
206 Intramyocyte detection of Epstein-Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy. Circulation 2004 0.76
207 Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy. Chest 2002 0.76
208 [Consensus document on endomyocardial biopsy of the Associazione per la Patologia Cardiovascolare Italiana]. G Ital Cardiol (Rome) 2009 0.76
209 Is it time for plakoglobin immune-histochemical diagnostic test for arrhythmogenic cardiomyopathy in the routine pathology practice? Cardiovasc Pathol 2013 0.75
210 Viral detection and tumor necrosis factor alpha profile in tracheal aspirates from children with suspicion of myocarditis. Diagn Mol Pathol 2008 0.75
211 Cardiac infections: focus on molecular diagnosis. Cardiovasc Pathol 2010 0.75
212 The changing spectrum of porcine bioprosthetic valve failure. Cardiovasc Pathol 2007 0.75
213 Comparison of United States and Italian experiences with sudden cardiac deaths in young competitive athletes: are the athletic populations comparable? Am J Cardiol 2010 0.75
214 When giant cell myocarditis affects only the atria. Circulation 2013 0.75
215 Reply to 'Anomalous left coronary artery origin from the pulmonary artery: an unusual late presentation of Bland-Garland-White syndrome'. J Cardiovasc Med (Hagerstown) 2010 0.75
216 The peritoneum as a natural scaffold for vascular regeneration. PLoS One 2012 0.75
217 Letter regarding article by Norman et al, "novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy". Circulation 2006 0.75
218 Assessing the significance of pathogenic mutations and autopsy findings in the light of 2010 arrhythmogenic right ventricular cardiomyopathy diagnostic criteria: a clinical challenge. Circ Cardiovasc Genet 2012 0.75
219 Endothelin A-receptor antagonist administration immediately after experimental myocardial infarction with reperfusion does not affect scar healing in dogs. Cardiovasc Res 2002 0.75
220 Durability of valve bioprostheses and the need of careful examination of explants. Ann Thorac Surg 2006 0.75
221 "Hibernating" myocardium: not only a matter of semantics. Circulation 2003 0.75
222 Sudden cardiac death associated with an extremely rare coronary anomaly of the left and right coronary arteries arising exclusively from the posterior (noncoronary) sinus of Valsalva. Clin Cardiol 2006 0.75
223 ECG-based screening: not only for athletes. Eur Heart J 2007 0.75
224 Incidence of sports-related sudden cardiac death: the Danish paradox. Heart Rhythm 2010 0.75
225 Achilles' heel of stentless porcine valves. Cardiovasc Pathol 2007 0.75
226 Pericardial traumatic injury in trans-catheter aortic valve implantation. Eur J Cardiothorac Surg 2012 0.75
227 Interventional procedures for atherothrombosis: pathology of retrieved material. Heart 2007 0.75
228 Expected freedom from structural degeneration and patient outgrowth for the bovine jugular vein conduit: is it possible to calculate a safe rate for children? Ann Thorac Surg 2003 0.75
229 Letter by Corrado et al regarding article, "sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006". Circulation 2009 0.75
230 Coronary artery bypass with glycerol-preserved saphenous vein allografts. Cardiovasc Dis 1981 0.75
231 Toronto porcine stentless valve and the need for something more. Cardiovasc Pathol 2006 0.75
232 The experience with porcine bioprostheses at Padua University. J Heart Valve Dis 2004 0.75
233 Prolonged durability of a Kay-Shiley mechanical valve prosthesis. Tex Heart Inst J 2006 0.75
234 Left ventricular noncompaction presenting like a double-chambered left ventricle. J Cardiovasc Med (Hagerstown) 2015 0.75
235 Arrhythmogenic cardiomyopathy: a biventricular disease in search of a cure. Heart Rhythm 2012 0.75
236 Coronary thrombosis and sudden death after an enteroviral infection. Case report. APMIS 2003 0.75
237 [Paradigm shifts in aortic pathology: clinical and therapeutic implications. Biology and pathology of the aortic wall]. G Ital Cardiol (Rome) 2013 0.75
238 Late coronary thrombosis following brachytherapy for vasospastic angina. Cardiovasc Pathol 2007 0.75
239 Sudden cardiac death in marathon runners: can it be prevented? Eur Heart J 2011 0.75
240 [Paradigm shifts in aortic pathology: clinical and therapeutic implications. Clinical imaging in chronic and acute aortic syndromes. The aorta as a cause of cardiac disease]. G Ital Cardiol (Rome) 2014 0.75
241 Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. J Dermatol Sci 2013 0.75
242 Calcified mass in the right atrium. Ann Thorac Surg 2005 0.75
243 Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009. Eur J Cardiovasc Prev Rehabil 2010 0.75
244 Management of arrhythmogenic right ventricular cardiomyopathy. Minerva Med 2016 0.75
245 Molecular basis and diagnosis of both inherited and acquired cardiovascular diseases: introduction. Cardiovasc Pathol 2010 0.75
246 The bovine jugular vein conduit for right ventricular outflow tract reconstruction: a feasible alternative to homograft conduits? J Thorac Cardiovasc Surg 2004 0.75
247 [Molecular investigation of sudden death]. G Ital Cardiol (Rome) 2007 0.75
248 Situs inversus with dextrocardia in a mummy case. Cardiovasc Pathol 2013 0.75
249 [Consensus statement of Multisocietary Task Force--prescription of physical exercise in the cardiological environment (First part)]. Monaldi Arch Chest Dis 2007 0.75
250 Age is a risk factor for maladaptive changes in rats exposed to increased pressure loading of the right ventricular myocardium. Cardiol Young 2007 0.75
251 Relation of aortic valve weight to severity of aortic stenosis. Am J Cardiol 2011 0.75
252 Mid-term follow-up in patients with Biocor porcine bioprostheses. Cardiovasc Surg 2002 0.75
253 Guidelines for autopsy investigation of sudden cardiac death. Cesk Patol 2010 0.75
254 Images in cardiovascular medicine. Calcification of the atrioventricular node in a fetus affected by congenital complete heart block. Circulation 2002 0.75
255 Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. J Neurol Neurosurg Psychiatry 2011 0.75
256 Scimitar syndrome associated with complete transposition of the great arteries. Eur Heart J 2013 0.75
257 Left main trunk ostial stenosis and aortic incompetence in Takayasu's arteritis. Cardiovasc Pathol 2002 0.75
258 Images in cardiovascular medicine: Giant right ventricular fibroma in an infant. Circulation 2002 0.75
259 [Preparticipation electrocardiographic screening for the prevention of sudden death in sports medicine]. G Ital Cardiol (Rome) 2011 0.75
260 Lipid insudation as a cause of structural failure of a stentless pericardial bioprosthesis. J Heart Valve Dis 2012 0.75
261 Pathological evidence of stem cell regeneration in the heart. Int J Cardiol 2004 0.75
262 [Sudden cardiac death in women]. G Ital Cardiol (Rome) 2012 0.75
263 The pathology of TRI-Tech valve leaflet escape. J Heart Valve Dis 2012 0.75
264 [4th centenary of the graduation of William Harvey from the university of Padova 1602-2002]. Ital Heart J Suppl 2002 0.75
265 [Diagnosis and therapy of arrhythmogenic right ventricular cardiomyopathy]. G Ital Cardiol (Rome) 2014 0.75
266 Long-term durability of a St. Jude medical X-cell bioprosthesis. Ann Thorac Surg 2012 0.75
267 BIOSA bileaflet pericardial valve: experimental study in sheep model. Cardiovasc Pathol 2004 0.75
268 [Bicuspid aortic valve]. G Ital Cardiol (Rome) 2012 0.75
269 The effects of basic fibroblast growth factor in an animal model of acute mechanically induced right ventricular hypertrophy. Cardiol Young 2012 0.75
270 Evolving role of cardiovascular pathology in clinical and surgical decision making. J Thorac Cardiovasc Surg 2005 0.75
271 CryoLife O'Brien aortic stentless prosthesis reoperations: clinical results and morphologic findings. Eur J Cardiothorac Surg 2013 0.75
272 Early calcification of a stentless pericardial bioprosthesis in the elderly. J Thorac Cardiovasc Surg 2008 0.75
273 Abnormal total ejection isovolume index as early noninvasive marker of chronic rejection in heart transplantation. Transpl Int 2005 0.75
274 Sinus node ablation for inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 2005 0.75
275 Left atrial myxoma in a child: case report and review of the literature. Cardiovasc Pathol 2003 0.75
276 Case report: fibroelastoma of the papillary muscle of the mitral valve: diagnostic implications and review of the literature. J Heart Valve Dis 2002 0.75
277 Age is a risk factor for maladaptive changes of the pulmonary root in rats exposed to increased pressure loading. Cardiovasc Pathol 2011 0.75
278 Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation. Xenotransplantation 2003 0.75
279 Images in cardiovascular medicine. Left ventricular mass after treatment with chemotherapic drugs. Circulation 2004 0.75
280 Are valve bioprostheses more prone to structural valve deterioration in mitral than in aortic position? An answer derived from a prolonged experience with the novacor left ventricular assist device. J Heart Lung Transplant 2004 0.75
281 [Cardiological protocols on evaluation of fitness for competitive sports]. Ital Heart J Suppl 2005 0.75
282 Diego Rivera's fresco and the case taken from Morgagni's De sedibus. Am J Cardiol 2013 0.75
283 Directional atherectomy of a calcified lesion using a new atherectomy device. Catheter Cardiovasc Interv 2002 0.75
284 Stem cells and cardiac hypertrophy. Cardiol Young 2005 0.75